Sun Pharma to launch complete range of generic anti-epilepsy drug


PTI, Feb 23, 2021, 4:28 PM IST

New Delhi: Sun Pharmaceutical Industries on Tuesday, February 23, said it plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the country at an affordable price.

The drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solution (10 mg/ml) and injectable (10 mg/ml) will be available in the market over the next few weeks.

Brivaracetam is approved by the Drugs Controller General of India (DCGI), as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.

”We are introducing the complete range of Brivaracetam in India at competitive pricing which will improve patient access. This product reaffirms our commitment towards improving epilepsy care by bringing multiple treatment options to patients and health care professionals in India,” Sun Pharma Chief Executive Officer – India Business Kirti Ganorkar said in a statement.

Brivaracetam belongs to the class of anti-epileptic drugs (AEDs) which have a unique or different mechanism of action compared to the existing treatment options. It has a fast onset of action and promising efficacy.

While epilepsy is a common neurological disorder, because of the social stigma surrounding the disease, cultural practices, and poor awareness of new treatment options, its management continues to be a challenge, the drug major said.

It is estimated that around 5.7 million to 6.4 million people in India suffer from epilepsy, it added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Adani announces Rs 65,000 cr investment in Rajasthan

Pakistan shock India for first T20 win over arch-rivals since 2016

Italy’s sister is trying to find escape route from country: Nalin against ‘Bharat Jodo Yatra’

Delhi Police arrest 2 men involved in terror acts

Maha: Man gives Rs 3 lakh for ‘US dollars’, gets packet full of scrap paper

Mani Ratnam’s ‘Ponniyin Selvan-I’ crosses Rs 300 crore mark worldwide

Delhi hospital performs 19th century procedure to save Iraqi national’s leg


Related Articles More

Adani announces Rs 65,000 cr investment in Rajasthan

RBI launches advanced supervisory monitoring system DAKSH

World Bank downgrades India’s economic growth forecast to 6.5 pc for FY23

Competition Commission gives conditional approval to Sony-Zee merger deal

Sensex climbs 513 points in early trade

MUST WATCH

Running Reace with Rahul Gandi and Siddaramiah

Uchila Dasara 2022 : Final Preparation for Precession

Bharath Judo : Rahul Gandhi Speach in Rain

Day 8 | Mahagauri

Sarapady Devadas Special Video.


Latest Additions

Adani announces Rs 65,000 cr investment in Rajasthan

Pakistan shock India for first T20 win over arch-rivals since 2016

Italy’s sister is trying to find escape route from country: Nalin against ‘Bharat Jodo Yatra’

Metastable commissions material processing facility near Bengaluru

Kharge rubbishes talk of him being ‘Sonia’s remote control’, slams BJP over its way of choosing party chiefs

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.